Harvard Business Publishing

Please click on the choices below to learn more about this product.

Ligand Pharmaceuticals Incorporated

Author(s): Nabil N. El-Hage and Michael Gorzynski

DOI: 10.1225/208019

• Learn More or Purchase This Case
• Related Titles on This Subject
  • Activists
    • AXA MONY
    • As Green As It Gets
    • Augusta National Golf Club Controversy (A)
    • Augusta National Golf Club Controversy (B)
    • More...
  • Finance
    • A Note on Private Equity in Developing Countries
    • A Primer on Valuing Simple Risk-Free Bonds
    • A Tale of Two Hedge Funds: Magnetar and Peloton
    • A User's Guide to the BOP and IIP
    • More...
  • Investments
    • 3i Group plc
    • A-Rod: Signing the Best Player in Baseball
    • ABRY Partners and F+W Publications
    • ALPES S.A.: A Joint Venture Proposal (A)
    • More...
• Other Items by the Authors
  • Nabil N. El-Hage
    • ABRY Fund V
    • ABRY Fund V
    • ABRY Partners and F+W Publications
    • ABRY Partners and F+W Publications
    • More...
• Business Fundamentals Series
• View All Cases

Powered by Content Directions, Inc. (CDI) and the Digital Object Identifier (DOI) View additional CDI examples     Want to Add This Link to Your Site?